Delisting risk
TransCode Therapeutics (RNAZ)
Develops RNA-delivery and immuno-oncology candidates for metastatic and other cancers.
$2.01
At close−0.05 (−2.43%)
Something off on this page? Send us feedback.
Next report
Nov 18, 2026
in 76 days
EPS estimate
—
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported−$16.61−$16.81−$4.94−$5.49−$16.42−$21.28−$7.17Pending
Estimate−$105.93−$3.21−$8.68−$9.24−$10.08———
Surprise+84.3%−423.7%+43.1%+40.6%−62.9%———
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported———————Pending
Estimate$300.0K$300.0K——————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | — | — | — |
| Aug 2026 | — | −$7.17 | — |
| May 2026 | — | −$21.28 | — |
| Apr 2026 | −$10.08 | −$16.42 | −62.9% |
| Nov 2025 | −$9.24 | −$5.49 | +40.6% |
The latest year is open to everyone — the 23 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Mar 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jul 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 18, 2026 | — | — | — | — | — | — | — |
| Aug 14, 2026 | — | −$7.17 | — | — | — | — | −5.8% |
| May 15, 2026 | — | −$21.28 | — | — | — | — | −6.5% |
| Apr 15, 2026 | −$10.08 | −$16.42 | −62.9% | — | — | — | −2.4% |
| Nov 14, 2025 | −$9.24 | −$5.49 | +40.6% | — | — | — | +1.8% |
The latest year is open to everyone — the 23 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 28, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 29, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 23, 2021 | |||||||
| Jul 9, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||